Mayo Clinic
Jacksonville, Florida, 32224, United States
NCT Number: NCT03480984
The researchers are trying to determine pain medication consumption in the first 24 hours after surgery in patients given the standard continuous infusion of local anesthetic versus patients given the same total dose via programmed intermittent dosing. Both groups will receive the option of patient controlled pain medication as well as the same dose of pre-programmed pain medication. The only difference is the rate of administration: continuous vs. hourly intervals.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Jacksonville, Florida, 32224, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via an hourly programmed bolus
6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via continuous infusion
Time frame: first 24 hours postoperatively
morphine equivalents of opioids in mg will be obtained from medical record
Time frame: first 48 hours postoperatively
morphine equivalents of opioids in mg will be obtained from medical record
Mayo Clinic
Other
A Comparison Between Continuous Versus Intermittent Bolus Infusion of Paravertebral Blocks for Thoracic Surgery: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07100821
Respiratory Tract Diseases, Thoracic Diseases
Al Mansurah, Egypt
View Trial DetailsNCT06546839
Lung Cancer, Lung Cancer Metastatic
Istanbul, Bagcilar, Turkey (Türkiye)
View Trial DetailsNCT04227717
Bone Diseases, Central Nervous System Diseases
New York, United States
View Trial DetailsNCT06180148
Respiratory Tract Diseases, Thoracic Diseases
Moscow, Russia
View Trial Details